ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"

Clinical trial NCT00051285 · TERMINATED

Trial details

NCT number: NCT00051285
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Failure, Congestive

Start date: 2002-02-01
Primary completion: 2005-06-01
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.